GSK126 25 mg | 99.67%
TargetMol
GSK126 is a excellently specific EZH2 methyltransferase inhibitor ( IC50=9.9 nM).
More Information Supplier PageGSK126
Search Results
GSK126 2 mg | 99.67%
TargetMol
GSK126 is a excellently specific EZH2 methyltransferase inhibitor ( IC50=9.9 nM).
More Information Supplier PageGSK126
GSK126 5 mg | 99.67%
TargetMol
GSK126 is a excellently specific EZH2 methyltransferase inhibitor ( IC50=9.9 nM).
More Information Supplier PageGSK126
GSK126 50 mg | 99.67%
TargetMol
GSK126 is a excellently specific EZH2 methyltransferase inhibitor ( IC50=9.9 nM).
More Information Supplier PageGSK126
Ponatinib 10 mg | 99.74%
TargetMol
Ponatinib is an orally available, multitargeted kinase inhibitor (IC50s: 0.37/1.1/1.5/2.2/5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively).
More Information Supplier PagePonatinib
Ponatinib 100 mg | 99.74%
TargetMol
Ponatinib is an orally available, multitargeted kinase inhibitor (IC50s: 0.37/1.1/1.5/2.2/5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively).
More Information Supplier PagePonatinib
Chlorambucil 200 mg | 99.58%
TargetMol
Chlorambucil is an orally-active antineoplastic aromatic nitrogen mustard. Chlorambucil alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.
More Information Supplier PageChlorambucil
Chlorambucil 100 mg | 99.58%
TargetMol
Chlorambucil is an orally-active antineoplastic aromatic nitrogen mustard. Chlorambucil alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.
More Information Supplier PageChlorambucil
Mubritinib 200 mg | 99.87%
TargetMol
Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2 with IC50 of 6 nM.
More Information Supplier PageMubritinib
Mubritinib 100 mg | 99.87%
TargetMol
Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2 with IC50 of 6 nM.
More Information Supplier PageMubritinib
